Metformin vs Glibenclamide: the first-line tablet or the old faithful for type 2 diabetes?
The short answer
Metformin is the global and Nigerian first choice for type 2 diabetes: it doesn't cause dangerous sugar crashes on its own, doesn't add weight, and protects long-term. Glibenclamide still has a place — it's cheap and effective — but it can drive blood sugar dangerously low, especially in older people or anyone who skips meals, which makes it a drug to use carefully, not casually.
Both tablets lower blood sugar, but by opposite philosophies. Metformin makes the body respond better to its own insulin and quiets the liver's excess sugar production — it almost never causes hypoglycaemia by itself. Glibenclamide squeezes the pancreas to release more insulin whether food is coming or not; miss lunch after your morning dose and your sugar can fall to genuinely dangerous levels. In markets where glibenclamide is bought loose and taken irregularly, that risk is not theoretical.
Metformin's own catch is stomach upset in the first weeks — starting low, taking it with food, and building up slowly usually solves it. Many Nigerians end up on both drugs together as diabetes progresses, which is legitimate combination therapy; what isn't legitimate is treating either as a licence to abandon diet, or stopping treatment because you feel normal. Diabetes control is measured, not felt.
Side by side
| Metformin | Glibenclamide | |
|---|---|---|
| How it works | Improves insulin sensitivity, calms liver sugar output | Forces the pancreas to release more insulin |
| Sugar-crash risk alone | Very low | Real — worst with skipped meals, alcohol, old age |
| Weight effect | Neutral, often slight loss | Tends to add weight |
| Main side effect | Early stomach upset (usually passes) | Hypoglycaemia |
| Guideline position | First-line worldwide and in Nigeria | Add-on / resource-limited alternative |
| Drug class | Biguanide antidiabetic | Sulfonylurea antidiabetic |
| Typical price | ₦1,500–₦18,000 online (median ₦6,670, July 2026) | ₦400–₦400 online (median ₦400, July 2026) |
| NAFDAC registrations | 35 active Greenbook listings | 5 active Greenbook listings |
| Common brands | Glucophage, Emzophage | Daonil, Semi-Daonil |
Prices are sampled from licensed Nigerian online pharmacies and span brands and pack sizes — indicative only. Registration counts are from our copy of the NAFDAC Greenbook (July 2026); listings can lag renewals.
Reach for Metformin when…
- •Newly diagnosed type 2 diabetes — this is where treatment starts
- •You're overweight or your meals are irregular
- •You're elderly or live alone (crash risk matters more)
Reach for Glibenclamide when…
- •A clinician added it because metformin alone no longer reaches target
- •Cost is the barrier to any treatment at all — with meal discipline and monitoring
- •You're already stable on it under supervision
Frequently asked questions
Educational comparison, not a prescription. Both medicines have full guides covering dosage, side effects, and warnings — talk to a pharmacist or doctor before switching. Updated July 2026.